AI Eye-Tracker could let macular disease patients skip clinic visits

This study tested a new, low-cost eye-tracking system called CRYSTALSIGHT that uses artificial intelligence to monitor macular diseases like age-related macular degeneration and diabetic retinopathy. Twenty participants used the device at home to track eye movements, and researchers compared its accuracy to a standard commercial eye tracker. The goal was to see if the system could help doctors remotely monitor disease activity without requiring frequent clinic visits.